


Ask a doctor about a prescription for Aescin
Aescin(Aescin Teva),
Escinum
Aescin and Aescin Teva are different trade names for the same medicine.
This medicine should always be used exactly as described in the patient leaflet or as directed by your doctor or pharmacist.
Aescin works as an anti-edema and anti-inflammatory agent, and it improves the condition of blood vessel tension. It reduces the permeability of blood vessel walls. It has been shown to be effective in the treatment of postoperative and post-traumatic edema.
Aescin causes faster absorption of post-traumatic hematomas and reduces the likelihood of their occurrence during the postoperative period (especially after orthopedic surgery). Additionally, by sealing the blood vessel endothelium, it improves lymphatic-venous circulation. The medicine is also used to prevent postoperative thrombophlebitis, as well as to treat disorders of venous circulation and varicose veins of the lower limbs.
If there is no improvement or if you feel worse, you should contact your doctor.
If you experience any of the following symptoms after using Aescin, you should contact your doctor immediately:
In case of concomitant use of anticoagulant medications, you should frequently monitor blood coagulation parameters.
It is essential to follow any other non-invasive measures recommended by your doctor, such as bandaging your legs, wearing compression stockings, or applying cold water compresses.
During treatment with Aescin, you should monitor your kidney function.
The medicine should not be used in patients with rare hereditary galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption syndrome.
Warning:using Aescin does not replace other preventive measures, such as cold water compresses or wearing compression stockings.
The use of Aescin is not recommended in children and adolescents under 18 years of age due to the lack of sufficient data confirming its safety in this age group.
You should tell your doctor about all the medicines you have taken recently, including those that are available without a prescription.
Aescin may enhance the effect of anticoagulant medications. Some antibiotics - cephalosporins may enhance the effect of Aescin.
You should avoid concomitant administration of Aescin with aminoglycoside antibiotics due to the possible increased toxic effect of aminoglycosides on the kidneys.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, you should consult your doctor or pharmacist before using this medicine.
There are no clinical data on the use of alpha-escin in pregnant women. Animal studies do not show any direct or indirect harmful effects of alpha-escin on pregnancy and fetal development.
There are no clinical data on the use of alpha-escin in breastfeeding women.
Aescin does not affect the ability to drive and use machines.
If you have been diagnosed with an intolerance to some sugars, you should consult your doctor before taking the medicine.
Due to the presence of orange yellow S (E 110), the medicine may cause allergic reactions.
This medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is considered "sodium-free".
This medicine should always be used exactly as directed by your doctor or pharmacist. If you are unsure, you should consult your doctor or pharmacist.
Aescin enteric-coated tablets are intended for oral use.
Use in children and adolescents:
Aescin is not recommended for use in children and adolescents under 18 years of age.
Adults:
The usual dose of Aescin is 3 times a day, 2 tablets, after meals, with a large amount of fluid.
Prophylactically, it can be used at least 16 hours before surgery. After 2-3 months of treatment, maintenance therapy can be used in a dose of 40 mg (2 tablets) 2 times a day.
In case of concomitant use of oral contraceptives, a double dose of alpha-escin can be taken.
Elderly patients:
no dose adjustment is necessary.
You should not take a double dose to make up for a missed dose.
Like all medicines, Aescin can cause side effects, although not everybody gets them.
Rare: allergic skin inflammation (itching, rash, redness, eruption, urticaria)
Very rare: severe allergic reactions (in some cases with bleeding); tachycardia, hypertension; hypersensitivity reactions; genital tract bleeding
Uncommon: dizziness, headache; nausea, vomiting, diarrhea, discomfort in the stomach
In case of the above reactions, especially bleeding and the first hypersensitivity reactions (skin rash), you should stop the medicine and consult your doctor.
If you experience any side effects, including any possible side effects not listed in the leaflet, you should tell your doctor or pharmacist.
Side effects can be reported directly to the Department of Post-Marketing Surveillance of Medicinal Products, Medical Devices, and Biocidal Products,
Jerozolimskie Avenue 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help gather more information on the safety of the medicine.
Store in a temperature below 25°C. Store in the original packaging to protect from moisture.
Keep out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
What Aescin contains
Enteric-coated tablets, in Al/PVC blisters, 30 tablets, 90 tablets in a cardboard box.
For more detailed information, you should contact the marketing authorization holder or the parallel importer.
Teva Pharmaceuticals CR, s.r.o.
Radlická 3185/1c
150 00 Prague 5
Czech Republic
TEVA Operations Poland Sp. z o.o.
Mogilska 80
31-546 Krakow
Poland
Medezin Sp. z o.o.
Zbąszyńska 3
91-342 Łódź
Medezin Sp. z o.o.
Zbąszyńska 3
91-342 Łódź
Laboratorium Galenowe Olsztyn Sp. z o.o.
Spółdzielcza 25A
11-001 Dywity
CEFEA Sp. z o.o. Sp. komandytowa
Działkowa 56
02-234 Warsaw
Pharma Innovations Sp. z o. o.
Jagiellońska 76
03-301 Warsaw
Marketing authorization number in the Czech Republic, the country of export: 85/262/92-C
Parallel import authorization number: 18/19
[Information about the trademark]
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Aescin – subject to medical assessment and local rules.